These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3120474

  • 21. Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.
    Porter JB, Morgan J, Hoyes KP, Burke LC, Huehns ER, Hider RC.
    Blood; 1990 Dec 01; 76(11):2389-96. PubMed ID: 2257308
    [Abstract] [Full Text] [Related]

  • 22. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
    Sheppard LN, Kontoghiorghes GJ.
    Arzneimittelforschung; 1993 Jun 01; 43(6):659-63. PubMed ID: 8352819
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
    Kontoghiorghes GJ, Chambers S, Hoffbrand AV.
    Biochem J; 1987 Jan 01; 241(1):87-92. PubMed ID: 3566714
    [Abstract] [Full Text] [Related]

  • 26. Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.
    Molenda JJ, Jones MM, Johnston DS, Walker EM, Cannon DJ.
    J Med Chem; 1994 Dec 09; 37(25):4363-70. PubMed ID: 7996548
    [Abstract] [Full Text] [Related]

  • 27. New orally active alpha-ketohydroxy pyridine chelators for the treatment of iron overload.
    Kontoghiorghes GJ.
    Birth Defects Orig Artic Ser; 1988 Dec 09; 23(5B):97-103. PubMed ID: 3390580
    [No Abstract] [Full Text] [Related]

  • 28. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
    Zanninelli G, Choudury R, Loréal O, Guyader D, Lescoat G, Arnaud J, Verna R, Cosson B, Singh S, Hider RC, Brissot P.
    J Hepatol; 1997 Jul 09; 27(1):176-84. PubMed ID: 9252093
    [Abstract] [Full Text] [Related]

  • 29. New orally active iron chelators.
    Kontoghiorghes GJ.
    Lancet; 1985 Apr 06; 1(8432):817. PubMed ID: 2858689
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelators. Possible implications on toxicity.
    Douvas GS, May MH, Kolnagou A, Kontoghiorghes GJ.
    Arzneimittelforschung; 2002 Apr 06; 52(1):45-52. PubMed ID: 11838274
    [Abstract] [Full Text] [Related]

  • 32. Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity.
    Bernhardt PV, Chin P, Sharpe PC, Wang JY, Richardson DR.
    J Biol Inorg Chem; 2005 Nov 06; 10(7):761-77. PubMed ID: 16193304
    [Abstract] [Full Text] [Related]

  • 33. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
    Eybl V, Caisová D, Koutenský J, Kontoghiorghes GJ.
    Arch Toxicol Suppl; 1991 Nov 06; 14():185-7. PubMed ID: 1805729
    [No Abstract] [Full Text] [Related]

  • 34. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP, Jones HM, Abeysinghe RD, Hider RC, Porter JB.
    Exp Hematol; 1993 Jan 06; 21(1):86-92. PubMed ID: 8417963
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions.
    Kontoghiorghes GJ.
    Hemoglobin; 2006 Jan 06; 30(2):183-200. PubMed ID: 16798643
    [Abstract] [Full Text] [Related]

  • 37. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu Z, Hider RC.
    J Med Chem; 1998 Aug 27; 41(18):3347-59. PubMed ID: 9719587
    [Abstract] [Full Text] [Related]

  • 38. Topical applications of iron chelators in photosensitization.
    Juzeniene A, Juzenas P, Iani V, Moan J.
    Photochem Photobiol Sci; 2007 Dec 27; 6(12):1268-74. PubMed ID: 18046481
    [Abstract] [Full Text] [Related]

  • 39. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ, Barr J, Baillod RA.
    Arzneimittelforschung; 1994 Apr 27; 44(4):522-6. PubMed ID: 8011008
    [Abstract] [Full Text] [Related]

  • 40. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
    Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA.
    Neurosci Lett; 2006 Oct 09; 406(3):189-93. PubMed ID: 16919875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.